Neurobiology of sleep and insomnia in children with CNS tumors
https://doi.org/10.17650/2311-1267-2018-5-4-51-59
Abstract
Insomnia is a common symptom in children with malignant diseases and especially in children with tumors of the central nervous system (CNS). However, little attention is paid this complication during the therapy of malignant neoplasms. Insomnia violates the quality of life of children and their immediate surroundings. In this article, the etiology, pathogenesis, and diagnostics are discussed in detail, and methods for treating this pathology are presented with two clinical cases confirming the diverse nature of insomnia in CNS tumors. Thus, the importance of an individual approach to the therapy of insomnia is emphasized.
Conflict of interest. The authors declare no conflict of interest.
Funding. The study was performed without external funding
About the Authors
N. A. Andreeva
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pediatric Oncologist Department of Clinical Oncology
Russian Federation
Pediatric Oncologist Department of Clinical Oncology
E. V. Kumirova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Dr. of Sci. (Med.), Pediatric Oncologist, Head of Department of Neurooncology
Russian Federation
Dr. of Sci. (Med.), Pediatric Oncologist, Head of Department of Neurooncology
References
1. Badin E., Haddad C., Shatkin J.P. Insomnia: the sleeping giant of pediatric public health. Curr Psychiatry Rep 2016;18(5):47. doi: 10.1007/s11920-016-0687-0.
2. Mai E., Buysse D.J. Insomnia: prevalence, impact, pathogenesis, diff erential diagnosis, and evaluation. Sleep Med Clin 2008;3(2):167–74. doi: 10.1016/j.jsmc.2008.02.001.
3. Zhou E.S., Manley P.E., Marcus K.J., Recklitis C.J. Medical and Psychosocial Correlates of Insomnia Symptoms in Adult Survivors of Pediatric Brain Tumors. J Pediatr Psychol 2016;41(6):623–30. doi: 10.1093/jpepsy/jsv071.
4. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005;3(5):349–59. PMID: 16218258.
5. Walter L.M., Nixon G.M., Davey M.J., Downie P.A., Horne R.S. Sleep and fatigue in pediatric oncology: A review of the literature. Sleep Med Rev 2015;24:71–82. doi: 10.1016/j.smrv.2015.01.001.
6. Bruni O., Angriman M. Pediatric insomnia: new insights in clinical assessment and treatment options. Arch Ital Biol 2015;153(2–3):144–56. doi: 10.12871/000398292015239.
7. Kales A., Rechtschaff en A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. NIH Publication 204. US Government Printing Offi ce, Washington, DC, 1968.
8. Berry R.B., Brooks R., Gamaldo C., Harding S.M., Lloyd R.M., Quan S.F., Troester M.T., Vaughn B.V. AASM scoring manual updates for 2017 (version 2.4). J Clin Sleep Med 2017;13(5):665–6. doi: 10.5664/jcsm.6576.
9. Bradley’s Neurology in Clinical Practice, 7th edition: Daroff R.B., Jankovic J., Mazziotta J.C., Pomeroy S.L., 2016.
10. Нейробиология сна: современный взгляд. Учебное пособие под ред. Петрова А.М., Гиниатуллина А.Р. Казань: КГМУ, 2012. [Neurobiology of sleep: a modern look. Textbook, ed. Petrov A.M., Giniatullin A.R. Kazan: KGMU, 2012. (In Russ.)].
11. Ковальзон В.М. Роль орексинергической системы мозга в регуляции бодрствования и сна. Эффективная фармакотерапия 2016;19:6–14. [Kovalzon V.M. The role of the orexinergic system of the brain in the regulation of wakefulness and sleep. Eff ektivnaya farmakoterapiya = Eff ective Pharmacotherapy 2016;19:6–14. (In Russ.)].
12. Savvidis C., Koutsilieris M. Circadian Rhythm Disruption in Cancer Biology. Mol Med 2012;18(1):1249–60. doi: 10.2119/molmed.2012.00077.
13. International Classifi cation of Sleep Disorders, 3rd edition. Darien, IL USA: American Academy of Sleep Medicine, 2014.
14. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th edition, 2013. 992 p.
15. Robertson M.E., McSherry F., Herndon J.E., Peters K.B. Insomnia and its associations in patients with recurrent glial neoplasms. Springerplus 2016:5(1):823. doi: 10.1186/s40064-016-2578-6.
16. Ciriaco M., Ventrice P., Russo G., Scicchitano M., Mazzitello G., Scicchitano F., Russo E. Corticosteroid-related central nervous system side eff ects. J Pharmacol Pharmacother 2013;4(5):94–8. doi: 10.4103/0976-500X.120975.
17. Sateia M.J., Buysse D.J., Krystal A.D., Neubauer D.N., Heald J.L. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017;13(2):307–49. doi: 10.5664/jcsm.6470.
18. Румянцев А.Г., Масчан А.А., Жуковская Е.В. и др. Детская гематология. Сборник клинических рекомендаций. М.: ГЭОТАР-Медиа, 2015. 656 c. [Rumyantsev A.G., Maschan A.A., Zhukovskaya E.V. et al. Pediatric Hematology. Collection of clinical guidelines. M.: GEOTAR-Media, 2015. 656 p. (In Russ.)].
19. Формуляр лекарственных средств в паллиативной педиатрии. Под ред. С. Джессэл и др. Пер. с англ. и редакция русской версии – Э.В. Кумирова. М.: Издательство «Проспект», 2013. 112 с. [Formulary of medicines in palliative pediatrics. Ed. S. Jessel et al. from english and editors of the russian version – E.V. Kumirova. M.: Prospect Publishing House, 2013. 112 p. (In Russ.)].
20. Kawabe K., Horiuchi F., Ochi M., Nishimoto K., Ueno S., Oka Y. Suvorexant for the Treatment of Insomnia in Adolescents. J Child Adolesc Psychopharmacol 2017;27(9):792–5. doi: 10.1089/cap.2016.0206.
Review
For citations:
Andreeva N.A., Kumirova E.V. Neurobiology of sleep and insomnia in children with CNS tumors. Russian Journal of Pediatric Hematology and Oncology. 2018;5(4):51-59. (In Russ.) https://doi.org/10.17650/2311-1267-2018-5-4-51-59
Views:
829
Email this article 